• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征的诊断与管理:一种适用于临床实践的简化算法。

Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

作者信息

Moayyedi Paul, Mearin Fermín, Azpiroz Fernando, Andresen Viola, Barbara Giovanni, Corsetti Maura, Emmanuel Anton, Hungin A Pali S, Layer Peter, Stanghellini Vincenzo, Whorwell Peter, Zerbib Frank, Tack Jan

机构信息

Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, ON, Canada.

Institute of Functional and Motor Digestive Disorders, Centro Médico Teknon, Barcelona, Spain.

出版信息

United European Gastroenterol J. 2017 Oct;5(6):773-788. doi: 10.1177/2050640617731968. Epub 2017 Sep 28.

DOI:10.1177/2050640617731968
PMID:29026591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5625880/
Abstract

BACKGROUND

Effective management of irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, can be challenging for physicians because of the lack of simple diagnostic tests and the wide variety of treatment approaches available.

OBJECTIVE

The objective of this article is to outline a simple algorithm for day-to-day clinical practice to help physicians navigate key stages to reaching a positive IBS diagnosis and guidance on how to prioritise the use of specific management strategies.

METHODS

This algorithm was based on the opinion of an expert panel evaluating current evidence.

RESULTS

The key principles forming the foundation of this evidence-supported algorithm are: confidently naming and explaining an IBS diagnosis for the patient, followed by assessment of key patient characteristics likely to influence the choice of therapy, such as predominant symptoms, and exploring the patient agenda and preferences. Consultation should always include education and reassurance with an explanatory model of IBS tailored to the patient. Individualised lifestyle changes, dietary modifications, pharmacological therapies, psychological strategies or a combination of interventions may be used to optimise treatment for each patient.

CONCLUSION

The simple visual tools developed here navigate the key stages to reaching a positive diagnosis of IBS, and provide a stepwise approach to patient-centred management targeted towards the most bothersome symptoms. Establishing a strong patient-physician relationship is central to all stages of the patient journey from diagnosis to effective management.

摘要

背景

肠易激综合征(IBS)是一种常见的功能性胃肠疾病,由于缺乏简单的诊断测试以及可用的治疗方法种类繁多,医生对其进行有效管理可能具有挑战性。

目的

本文的目的是概述一种适用于日常临床实践的简单算法,以帮助医生在关键阶段做出IBS的阳性诊断,并指导如何优先使用特定的管理策略。

方法

该算法基于评估当前证据的专家小组的意见。

结果

构成这一有证据支持的算法基础的关键原则是:向患者自信地说明并解释IBS诊断,随后评估可能影响治疗选择的关键患者特征,如主要症状,并探究患者的议程和偏好。咨询应始终包括采用为患者量身定制的IBS解释模型进行教育和安抚。可采用个性化的生活方式改变、饮食调整、药物治疗、心理策略或多种干预措施相结合的方式,为每位患者优化治疗。

结论

此处开发的简单可视化工具可指导做出IBS阳性诊断的关键阶段,并提供一种针对最困扰症状的以患者为中心的管理的逐步方法。建立牢固的医患关系是患者从诊断到有效管理的整个过程所有阶段的核心。

相似文献

1
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.肠易激综合征的诊断与管理:一种适用于临床实践的简化算法。
United European Gastroenterol J. 2017 Oct;5(6):773-788. doi: 10.1177/2050640617731968. Epub 2017 Sep 28.
2
Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.电话式认知行为疗法和基于网络的认知行为疗法联合常规治疗与常规治疗对照治疗难治性肠易激综合征的 ACTIB 三臂 RCT 研究。
Health Technol Assess. 2019 Apr;23(17):1-154. doi: 10.3310/hta23170.
3
Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.肠易激综合征的诊断与治疗:综述
JAMA. 2021 Mar 2;325(9):865-877. doi: 10.1001/jama.2020.22532.
4
Management of the multiple symptoms of irritable bowel syndrome.肠易激综合征多种症状的管理。
Lancet Gastroenterol Hepatol. 2017 Feb;2(2):112-122. doi: 10.1016/S2468-1253(16)30116-9. Epub 2017 Jan 12.
5
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.美国胃肠病学会关于饮食在肠易激综合征中作用的临床实践更新:专家综述。
Gastroenterology. 2022 May;162(6):1737-1745.e5. doi: 10.1053/j.gastro.2021.12.248. Epub 2022 Mar 23.
6
Diagnosis and management of IBS.肠易激综合征的诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):565-81. doi: 10.1038/nrgastro.2010.137.
7
Practical management of irritable bowel syndrome: a clinical review.肠易激综合征的实用管理:一项临床综述。
Minerva Gastroenterol Dietol. 2016 Mar;62(1):30-48. Epub 2015 Oct 8.
8
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.2020 年肠易激综合征循证临床实践指南。
J Gastroenterol. 2021 Mar;56(3):193-217. doi: 10.1007/s00535-020-01746-z. Epub 2021 Feb 4.
9
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).加拿大胃肠病学协会肠易激综合征(IBS)管理临床实践指南
J Can Assoc Gastroenterol. 2019 Apr;2(1):6-29. doi: 10.1093/jcag/gwy071. Epub 2019 Jan 17.
10
Irritable bowel syndrome: the clinical approach.肠易激综合征:临床方法。
Panminerva Med. 2018 Dec;60(4):213-222. doi: 10.23736/S0031-0808.18.03541-3. Epub 2018 Sep 24.

引用本文的文献

1
Expectations of the adult population of the Hashemite Kingdom of Jordan about irritable bowel syndrome.约旦哈希姆王国成年人口对肠易激综合征的期望。
Medicine (Baltimore). 2025 Aug 15;104(33):e43964. doi: 10.1097/MD.0000000000043964.
2
PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress.过氧化物酶体增殖物激活受体γ(PPARγ)激活通过减轻氧化应激来减轻新生期慢性限制性应激(CRD)诱导的雄性大鼠内脏痛觉过敏和焦虑。
BMC Gastroenterol. 2025 Jan 20;25(1):22. doi: 10.1186/s12876-025-03618-3.
3
Nurse-led self-management support to improve symptom management and self-reported outcomes in people with irritable bowel syndrome.护士主导的自我管理支持,以改善肠易激综合征患者的症状管理和自我报告的结果。
Interdiscip Nurs Res. 2024 Sep 26;3(3):163-168. doi: 10.1097/NR9.0000000000000069. eCollection 2024 Sep.
4
Exploring online health resources and self-care among irritable bowel syndrome patients: analyzing internet use and AI chatbot interactions.探索肠易激综合征患者的在线健康资源与自我护理:分析互联网使用情况及与人工智能聊天机器人的互动
Mhealth. 2024 Oct 23;10:28. doi: 10.21037/mhealth-24-14. eCollection 2024.
5
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.用于治疗肠易激综合征的益生菌和益生元——一篇叙述性综述
J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337.
6
Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives.新型美贝维林衍生物的解痉活性和抗炎作用
Biomedicines. 2024 Oct 12;12(10):2321. doi: 10.3390/biomedicines12102321.
7
The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial.昂丹司琼对腹泻型肠易激综合征患者症状改善的影响:一项随机对照试验
Middle East J Dig Dis. 2024 Jul;16(3):178-184. doi: 10.34172/mejdd.2024.386. Epub 2024 Jul 31.
8
Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis.麸质限制用于肠易激综合征:是与否?一项GRADE评估的系统评价和荟萃分析
Front Nutr. 2023 Nov 1;10:1273629. doi: 10.3389/fnut.2023.1273629. eCollection 2023.
9
Circadian rhythms in colonic function.结肠功能的昼夜节律。
Front Physiol. 2023 Aug 30;14:1239278. doi: 10.3389/fphys.2023.1239278. eCollection 2023.
10
Evaluation of the Impact of Some Single-Nucleotide Gene Polymorphisms on the Development of Adenomatous Polyps of the Colon in Patients with Irritable Bowel Syndrome.评价某些单核苷酸基因多态性对伴有肠易激综合征的结肠腺瘤性息肉发展的影响。
Turk J Gastroenterol. 2023 Aug;34(8):822-830. doi: 10.5152/tjg.2023.21985.

本文引用的文献

1
Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.感染后肠易激综合征、热带口炎性腹泻和小肠细菌过度生长:缺失的环节。
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):435-441. doi: 10.1038/nrgastro.2017.37. Epub 2017 May 17.
2
Management of the multiple symptoms of irritable bowel syndrome.肠易激综合征多种症状的管理。
Lancet Gastroenterol Hepatol. 2017 Feb;2(2):112-122. doi: 10.1016/S2468-1253(16)30116-9. Epub 2017 Jan 12.
3
Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.腹泻型肠易激综合征的现有及新出现的药物治疗:实践中的循证治疗
Therap Adv Gastroenterol. 2017 Feb;10(2):253-275. doi: 10.1177/1756283X16663396. Epub 2016 Sep 16.
4
Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.罗马标准在基层医疗中用于诊断肠易激综合征:一项欧洲国家间的调查
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):651-656. doi: 10.1097/MEG.0000000000000848.
5
Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis.心理疗法改善肠易激综合征患者心理健康和日常功能的疗效比较:系统评价和荟萃分析。
Clin Psychol Rev. 2017 Feb;51:142-152. doi: 10.1016/j.cpr.2016.11.001. Epub 2016 Nov 8.
6
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.一项比较低FODMAP饮食与改良版英国国家卫生与临床优化研究所(NICE)指南对美国患有腹泻型肠易激综合征(IBS-D)成年人疗效的随机对照试验。
Am J Gastroenterol. 2016 Dec;111(12):1824-1832. doi: 10.1038/ajg.2016.434. Epub 2016 Oct 11.
7
World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome: A Global Perspective Update September 2015.世界胃肠病学组织全球指南:肠易激综合征——全球视角更新(2015年9月)
J Clin Gastroenterol. 2016 Oct;50(9):704-13. doi: 10.1097/MCG.0000000000000653.
8
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.利福昔明重复治疗对腹泻型肠易激综合征患者安全有效。
Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13.
9
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.通过补充病史和有限的诊断评估提高肠易激综合征症状性标准的诊断性能。
Am J Gastroenterol. 2016 Oct;111(10):1446-1454. doi: 10.1038/ajg.2016.308. Epub 2016 Aug 2.
10
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.低发酵性寡糖、双糖、单糖与多元醇饮食治疗肠易激综合征的疗效:迄今的证据
Clin Exp Gastroenterol. 2016 Jun 17;9:131-42. doi: 10.2147/CEG.S86798. eCollection 2016.